21/11/2025
🌟 FamiCord Group Named Europe’s Leading Stem Cell Bank by Life Sciences Review 🌟
We’re proud to announce that our parent company, FamiCord Group, has been recognised by Life Sciences Review as “Europe’s Leading Stem Cell Bank 2025” — an acknowledgement of excellence, innovation and leadership in the field of stem-cell banking.
Here’s what makes this achievement so meaningful for you and your family:
✅ Industry-leading scale & trust — FamiCord Group is the largest stem cell bank in Europe and among the top globally.
✅ Proven treatment record — The group has supported thousands of patients, supplying stem-cell therapies for both standard transplants and newer regenerative-medicine applications.
✅ Deep experience in collection, processing & long-term storage — From the moment cord blood/tissue is collected at birth, through certified labs and cryopreservation, FamiCord handles all the steps and makes them accessible across many countries.
✅ Innovating for the future — FamiCord isn’t just about storage. It’s actively involved in advancing stem cell therapies (for example, breakthroughs in expanded cord-blood uses) and partnering in research.
If you’re expecting a baby or thinking about preparing for future health options, now is a great time to look into storing cord-blood and tissue stem cells through a provider with strong credentials and innovation momentum.
🔗 Click the link to read the full story and learn how FamiCord’s award reflects the service you can trust: https://www.smartcells.com/famicord-group-named-europes-leading-stem-cell-bank-by-life-sciences-review/